About Us

BRIEF-Sarepta Therapeutics anticipates net revenues for the year to exceed $95 mln

* Sarepta Therapeutics - in Q1, recognized net revenues of $16.3 million in product sales; no revenue was recognized for the same period of 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.